Theory Financial’s Eli Lilly LLY Stock Holding History

Theory Financial’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$391K	Sell	338 -16	-5%	-$18.9K	0.12%	81
2026 Q2	$425K	Buy	354 +28	+9%	+$28.6K	0.13%	77
2026 Q1	$300K	Buy	326 +79	+32%	+$80.1K	0.11%	83
2025 Q4	$262K	Sell	247 -8	-3%	-$7.65K	0.09%	91
2025 Q3	$206K	Buy	+255	New	+$190K	0.07%	90
2025 Q2	–	Sell	-280	Closed	-$231K	–	92
2025 Q1	$231K	Buy	+280	New	+$233K	0.1%	74
2023 Q4	–	Sell	-1,715	Closed	-$921K	–	73
2023 Q3	$921K	Sell	1,715 -121	-7%	-$62.4K	0.54%	38
2023 Q2	$861K	Hold	1,836	–	–	0.5%	38
2023 Q1	$631K	Hold	1,836	–	–	0.38%	43
2022 Q4	$672K	Buy	+1,836	New	+$651K	0.44%	41

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Theory Financial's LLY Position: Q3 2026 in Review

Theory Financial reduced its Eli Lilly (LLY) stake by 4.5% in Q3 2026, selling an estimated $18.9K and leaving 338 shares worth $391K. The position accounts for 0.12% of the portfolio, ranked #81.

Theory Financial first reported a position in LLY in Q4 2022 and has held it in 10 quarters since. The position peaked at $921K in Q3 2023. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Theory Financial held 338 shares of Eli Lilly worth $391K as of Q3 2026.
Theory Financial sold 16 Eli Lilly shares in Q3 2026, an estimated $18.9K.
Eli Lilly made up 0.12% of Theory Financial's portfolio in Q3 2026, its #81 holding.
Theory Financial first reported a position in Eli Lilly in Q4 2022 and has held it in 10 quarters since.
Theory Financial's Eli Lilly position peaked at $921K in Q3 2023.
4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Theory Financial's 13F filing for Q3 2026, filed 9 Nov 2026.